Expert Review of Vaccines

Vaccines and global stability: achievements and challenges
pp. 1457-1460(4)
Author: Van der Zeijst, Bernard AM

News in brief
pp. 1461-1463(3)

AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention
pp. 1465-1473(9)
Author: Schwarz, Tino F

RotaTeq™: a three-dose oral pentavalent reassortant rotavirus vaccine
pp. 1475-1480(6)
Authors: Chandran, Aruna; Santosham, Mathuram

Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm
pp. 1481-1492(12)
Authors: Bottazzi, Maria Elena; Brown, Ami Shah

Herd immunity: recent uses in vaccine assessment
pp. 1493-1506(14)
Authors: Gonçalves, Guilherme

Emerging applications of anticytokine vaccines
pp. 1507-1517(11)
Authors: Delavallée, Laure; Assier, Eric; Semerano, Luca; Bessis, Natacha; Boissier, Marie-Christophe

Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants
pp. 1519-1532(14)
Authors: Kim, Sungjune; Lalani, Saif; Parekh, Vrajesh V; Wu, Lan; Van Kaer, Luc

Peptide-based vaccines for cancer: realizing their potential
pp. 1533-1545(13)
Authors: Kanodia, Shreya; Kast, W Martin

Overview of mimotopes and related strategies in tumor vaccine development
pp. 1547-1555(9)
Authors: Zhao, Lina; Liu, Zhiguo; Fan, Daiming

Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis
pp. 1557-1567(11)
Authors: Henke, Andreas; Jarasch, Nadine; Wutzler, Peter

Pertussis in Latin America: current situation and future vaccination challenges
pp. 1569-1580(12)
Authors: Ulloa-Gutierrez, Rolando; Avila-Aguero, María L

Acknowledgements
pp. 1591-1591(1)